Springer Protocols: Abstract: 11. Public Consortium Efforts in Toxicogenomics

11. Public Consortium Efforts in Toxicogenomics

By: William B. Mattes⁴

Abstract

Full Text

Download PDF (434K)

Public consortia provide a forum for addressing questions requiring more resources than one organization alone could bring to bear and engaging many sectors of the scientific community. They are particular well suited for tackling some of the questions encountered in the field of toxicogenomics, where the number of studies and microarray analyses would be prohibitively expensive for a single organization to carry out. Five consortia that stand out in the field of toxicogenomics are the Institutional Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) Committee on the Application of Genomics to Mechanism Based Risk Assessment, the Toxicogenomics Research Consortium, the MicroArray Quality Control (MAQC) Consortium, the InnoMed PredTox effort, and the Predictive Safety Testing Consortium. Collectively, these consortia efforts have addressed issues such as reproducibility of microarray results, standard practice for assays and analysis, relevance of microarray results to conventional end points, and robustness of statistical models on diverse data sets. Their results demonstrate the impact that the pooling of resources, experience, expertise, and insight found in consortia can have.

Affiliation(s): (4) Department of Toxicology, The Critical Path Institute, Rockville, Maryland

Book Title: Essential Concepts in Toxicogenomics

Series: Methods in Molecular Biology | Volume: 460 | Pub. Date: Oct-01-2008 | Page Range: 221-238 | DOI: 10.1007/978-1-60327-048-9_11

Subject: Pharmacology/Toxicology

Key Words: consortia - public-private partnerships - standards - toxicogenomics

References

Download References

1.	Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470.

2.	DeRisi, J. L., Iyer, V. R., and Brown, P. O. (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680–686.

3.	Anderson, N. L., Taylor, J., Hofmann, J. P., Esquer-Blasco, R., Swift, S., and Anderson, N. G. (1996) Simultaneous measurement of hundreds of liver proteins: application in assessment of liver function. Toxicol. Pathol. 24, 72–76.

4.	Kegelmeyer, A. E., Sprankle, C. S., Horesovsky, G. J., and Butterworth, B. E. (1997) Differential display identified changes in mRNA levels in regenerating livers from chloroform-treated mice. Mol. Carcinog. 20, 288–297.

5.	Rodi, C. P., Bunch, R. T., Curtiss, S. W., Kier, L. D., Cabonce, M. A., Davila, J. C., et al. (1999) Revolution through genomics in investigative and discovery toxicology. Toxicol. Pathol. 27, 107–110.

6.	Amundson, S. A., Bittner, M., Chen, Y., Trent, J., Meltzer, P., and Fornace, A. J. (1999) Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18, 3666–3672.

7.	Farr, S., and Dunn, R. T., 2nd. (1999) Concise review: gene expression applied to toxicology. Toxicol. Sci. 50, 1–9.

8.	Fornace, A. J., Amundson, S. A., Bittner, M., Myers, T. G., Meltzer, P., Weinstein, J. N., and Trent, J. (1999) The complexity of radiation stress responses: analysis by informatics and functional genomics approaches. Gene. Expr. 7, 387–400.

9.	Jelinsky, S. A., and Samson, L. D. (1999) Global response of Saccharomyces cerevisiae to an alkylating agent. Proc. Natl. Acad. Sci. U. S. A. 96, 1486–1491.

10.	Nuwaysir, E. F., Bittner, M., Trent, J., Barrett, J. C., and Afshari, C. A. (1999) Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog. 24, 153–159.

11.	Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14, 1675–1680.

12.	Shalon, D., Smith, S. J., and Brown, P. O. (1996) A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 6, 639–645.

13.	Stimpson, D. I., Cooley, P. W., Knepper, S. M., and Wallace, D. B. (1998) Parallel production of oligonucleotide arrays using membranes and reagent jet printing. BioTechniques 25, 886–890.

14.	Ermolaeva, O., Rastogi, M., Pruitt, K. D., Schuler, G. D., Bittner, M. L., Chen, Y., et al. (1998) Data management and analysis for gene expression arrays. Nat. Genet. 20, 19–23.

15.	Bassett, D. E., Eisen, M. B., and Boguski, M. S. (1999) Gene expression informatics—it’s all in your mine. Nat. Genet. 21, 51–55.

16.	Zhang, M. Q. (1999) Large-scale gene expression data analysis: a new challenge to computational biologists. Genome Res. 9, 681–688.

17.	Brazma, A., and Vilo, J. (2000) Gene expression data analysis. FEBS Lett. 480, 17–24.

18.	ILSI. About ILSI. Available at www.ilsi.org/AboutILSI/.

19.	ILSI. Application of Genomics to Mechanism-based Risk Assessment. Available at www.hesiglobal.org/Committees/TechnicalCommittees/Genomics/.

20.	Parkinson, H., Kapushesky, M., Shojatalab, M., Abeygunawardena, N., Coulson, R., Farne, A., et al. (2007) ArrayExpress–a public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 35, D747–750.

21.	ILSI HESI. Genomics Committee Status Report 2003. Available at www.hesiglobal.org/NR/rdonlyres/8F5B8FD4-B2C6–4DD0-A6D8-F5CBD60D8B13/0/CommitteeStatusReport.pdf.

22.	Pennie, W., Pettit, S. D., and Lord, P. G. (2004) Toxicogenomics in risk assessment: an overview of an HESI collaborative research program. Environ. Health Perspect. 112, 417–419.

23.	Baker, V. A., Harries, H. M., Waring, J. F., Duggan, C. M., Ni, H. A., Jolly, R. A., et al. (2004) Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays. Environ. Health Perspect. 112, 428–438.

24.	Ulrich, R. G., Rockett, J. C., Gibson, G. G., and Pettit, S. D. (2004) Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression. Environ. Health Perspect. 112, 423–427.

25.	Thompson, K. L., Afshari, C. A., Amin, R. P., Bertram, T. A., Car, B., Cunningham, M., et al. (2004) Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. Environ. Health Perspect. 112, 488–494.

26.	Kramer, J. A., Pettit, S. D., Amin, R. P., Bertram, T. A., Car, B., Cunningham, M., et al. (2004) Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ. Health Perspect. 112, 460–464.

27.	Amin, R. P., Vickers, A. E., Sistare, F., Thompson, K. L., Roman, R. J., Lawton, M., et al. (2004) Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. 112, 465–479.

28.	Jolly, R. A., Goldstein, K. M., Wei, T., Gao, H., Chen, P., Huang, S., et al. (2005) Pooling samples within microarray studies: a comparative analysis of rat liver transcription response to prototypical toxicants. Physiol. Genomics 22, 346–355.

29.	Waring, J. F., Ulrich, R. G., Flint, N., Morfitt, D., Kalkuhl, A., Staedtler, F., et al. (2004) Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene. Environ. Health Perspect. 112, 439–448.

30.	Chu, T. M., Deng, S., Wolfinger, R., Paules, R. S., and Hamadeh, H. K. (2004) Cross-site comparison of gene expression data reveals high similarity. Environ. Health Perspect. 112, 449–455.

31.	Hamadeh, H. K., Knight, B. L., Haugen, A. C., Sieber, S., Amin, R. P., Bushel, P. R., et al. (2002) Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol. Pathol. 30, 470–482.

32.	Mattes, W. B. (2004) Annotation and cross-indexing of array elements on multiple platforms. Environ. Health Perspect. 112, 506–510.

33.	Goodsaid, F. M., Smith, R. J., and Rosenblum, I. Y. (2004) Quantitative PCR deconstruction of discrepancies between results reported by different hybridization platforms. Environ. Health Perspect. 112, 456–460.

34.	NIEHS. Introduction to the Toxicogenomics Research Consortium (TRC). Available at www.niehs.nih.gov/dert/trc/intro.htm.

35.	Medlin, J. (2002) Toxicogenomics research consortium sails into uncharted waters. Environ. Health Perspect. 110, A744–746.

36.	Hosack, D. A., Dennis, G., Jr., Sherman, B. T., Lane, H. C., Lempicki, R. A., Yang, J., and Gao, W. (2003) Identifying biological themes within lists of genes with EASE. Genome Biol. 4, R70.

37.	Camon, E., Magrane, M., Barrell, D., Binns, D., Fleischmann, W., Kersey, P., et al. (2003) The Gene Ontology Annotation (GOA) project: implementation of GO in SWISS-PROT, TrEMBL, and InterPro. Genome Res. 13, 662–672.

38.	Tong, W., Lucas, A. B., Shippy, R., Fan, X., Fang, H., Hong, H., et al. (2006) Evaluation of external RNA controls for the assessment of microarray performance. Nat. Biotechnol. 24, 1132–1139.

39.	Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., et al. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24, 1151–1161.

40.	Canales, R. D., Luo, Y., Willey, J. C., Austermiller, B., Barbacioru, C. C., Boysen, C., et al. (2006) Evaluation of DNA microarray results with quantitative gene expression platforms. Nat. Biotechnol. 24, 1115–1122.

41.	Patterson, T. A., Lobenhofer, E. K., Fulmer-Smentek, S. B., Collins, P. J., Chu, T. M., Bao, W., Fet al. (2006) Performance comparison of one-color and two-color platforms within the Microarray Quality Control (MAQC) project. Nat. Biotechnol. 24, 1140–1150.

42.	Guo, L., Lobenhofer, E. K., Wang, C., Shippy, R., Harris, S. C., Zhang, L., et al. (2006) Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat. Biotechnol. 24, 1162–1169.

43.	InnoMed PredTox. Available at www.innomed-predtox.com/.

44.	FDA. (2006) Critical Path Opportunities Report and List (HHS, ed.). FDA, Bethesda, MD.

45.	FDA. FDA and the Critical Path Institute Announce Predictive Safety Testing Consortium. Available at www.fda.gov/bbs/topics/news/2006/NEW01337.html.

46.	Fielden, M. R., Brennan, R., and Gollub, J. (2007) A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol. Sci. 99, 90–100.

47.	Nie, A. Y., McMillian, M., Parker, J. B., Leone, A., Bryant, S., Yieh, L., et al. (2006) Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol. Carcinog. 45, 914–933.

Comments (Loading...)

Post comment/View all comments